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ABSTRACT 
Nephrocalcinosis involves the deposition of microscopic crystals in the tubular lumen or 
interstitium. While the clinical, biochemical and genetic aspects of the diseases causing 
nephrocalcinosis have been elucidated, little is known about the cellular events in this 
calcification process. We previously reported a phenomenon involving the spontaneous 
formation of Ca2PO4 nodules in primary papillary renal cells from a patient with medullary 
nephrocalcinosis harboring a rare GDNF gene variant. We also demonstrated that cultivating 
GDNF-silenced HK-2 cells in osteogenic conditions for 15 days triggered Ca2PO4 deposits. 
Given the reportedly close relationship between cell death and pathological calcification, the 
aim of this study was to investigate whether apoptosis is involved in the calcification of 
GDNF-silenced HK-2 cells under osteogenic conditions. Silenced and control cells were 
cultured in standard and osteogenic medium for 1, 5 and 15 days, and any Ca2PO4 deposition 
was identified by means of von Kossa staining and ESEM analyses. Based on the results of 
annexin V and propidium iodide analysis, and TUNEL assay, the silenced cells in the 
osteogenic medium showed a significant increase in the percentage of cells in the late phase 
of apoptosis and an increased Ca2PO4 deposition at 15 days.  The results of qRT-PCR of BAX 
and BCL2, and in-cell Western analysis of caspases indicated that the cell death process was 
independent of caspase-3, -6, -7 and -9 activation, however. Using this model, we provide 
evidence of caspase-independent cell death triggering the calcification process in GDNF-
silenced HK-2 cells.  
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Abbreviations list: 
GDNF: glial-cell-derived neurotrophic factor  
HK-2: human kidney-2 
ESEM: environmental scanning electron microscope  
TUNEL: terminal deoxynucleotidyl transferase dUTP nick end labeling  
qRT-PCR: quantitative real-time polymerase chain reaction 
MSK: medullary sponge kidney 
VSMC: vascular smooth muscle cell 
ATCC: American type culture collection 
shRNA: short hairpin RNA 
ICC: immunocytochemistry 
RT: room temperature 
WT: wild type 
ALP: alkaline phosphatase 
PI: propidium iodide 
FITC: fluorescein isothiocyanate 
NCBI: National Center for Biotechnology Information 
GAPDH: glyceraldehyde 3-phosphate dehydrogenase 
HPRT: hypoxanthine guanine phosphoribosyl transferase 
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MIQE: minimum information for publication of quantitative real-time PCR experiments 
nRQ: normalized relative quantities 
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INTRODUCTION 
Many in vitro and in vivo studies on the mechanisms underlying calcium nephrolithiasis have 
provided evidence of a condition frequently associated with nephrocalcinosis, which 
involving the deposition of microscopic crystals in the tubular lumen (intratubular 
nephrocalcinosis) or interstitium (interstitial nephrocalcinosis) (1-3). While the clinical, 
biochemical and genetic aspects of the diseases causing nephrocalcinosis have been 
thoroughly elucidated, little is known about the specific cellular events involved in this 
calcification process. The most accredited hypothesis to explain the onset of interstitial 
nephrocalcinosis is purely physicochemical and related to spontaneous Ca2PO4 crystallization 
in the interstitium due to calcium and phosphate oversaturation in this milieu (4, 5). Exactly 
how the tubulo-interstitial cells respond to the influx of these potentially precipitating ions is 
still unknown. We were the first to suggest that nephrocalcinosis might be an osteogenic-like 
cell-driven process (6, 7), and our previous studies provided the first evidence of human renal 
cells undergoing calcification under certain circumstances, such as GDNF gene down-
regulation, in much the same way as in vascular calcification (8). We had the chance to 
observe spontaneous instances of this phenomenon in primary renal cells derived from a 
patient with medullary sponge kidney (MSK) and interstitial nephrocalcinosis who carried a 
GDNF gene mutation. We also demonstrated that, when exposed to an osteogenic medium, 
renal tubular HK-2 cells with a silenced GDNF expression were better able to produce 
Ca2PO4 deposits than control cells by shifting the osteonectin/osteopontin ratio in favor of 
osteonectin. This finding was the first indication of a role for GDNF in the tubular renal cell 
calcification process (8).  
A fundamental question remaining to be answered concerns the cellular mechanisms by 
means of which GDNF down-regulation promotes the calcification process. The assumption 
explored in the present study was that down-regulated GDNF could favor cell death 
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phenomena, and apoptosis in particular. The importance of cell death in pathological 
calcification has been well documented (9-12). It has been claimed, for instance, that 
chondrocyte-derived apoptotic bodies might contribute to the calcification of articular 
cartilage (10). In advanced carotid atherosclerotic plaques, matrix vesicle-like structures 
derived from vascular smooth muscle cells (VSMCs) were found to contain high levels of 
BAX, a pro-apoptotic member of the BCL2 family, indicating that they may be remnants of 
apoptotic cells (11, 12). Apoptotic VSMC-derived matrix vesicle-like structures can also 
concentrate and crystallize calcium, triggering calcification (12-15). These findings suggest 
that calcification may be initiated by apoptotic bodies in cooperation with matrix vesicles. It 
has long been known that pathological calcification follows necrosis in cardiovascular tissues 
and in the kidney (16-18). In normal bone formation too, calcification is initiated in matrix 
vesicles, released from osteoblasts and hypertrophic chondrocytes, and facilitated by 
apoptotic bodies (19-23).  
All these findings led to the idea that cell death could be important in initiating ectopic 
calcification in renal cells under certain conditions. To test our hypothesis, we used a 
previously-adopted in vitro experimental model of down-regulated GDNF in HK-2 cells (8). 
This enabled us to demonstrate that cell death can trigger the calcification process in renal 
tubular cells, and that GDNF down-regulation strongly facilitates this process. We thus 
confirmed the role of GDNF as an adaptive survival factor, and its alteration appears to have a 
key role in nephrocalcinosis. We also discovered that, in GDNF-silenced cells, death occurs 
in a programmed but caspase-independent manner. 
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EXPERIMENTAL 
Cell culture  
The human renal proximal tubular cell line HK-2 (human kidney-2) was purchased from 
ATCC (CRL-2190™). HK-2 cells were maintained in a mixture of Ham’s F12 and 
Dulbecco’s modified Eagle’s growth medium (DMEM/F12; EuroClone, Celbio) 
supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS), 2 mM L-glutamine, 
100 U/ml penicillin and 100 μg/ml streptomycin (EuroClone, Celbio). Cells were grown in a 
humidified atmosphere of 5% CO2 and 95% air at 37°C. The cells were seeded at an 
appropriate cell density for different assays and left to grow to 80% confluence, then cell 
synchronization was performed routinely by incubating cells in serum-free medium for 24 h 
prior to each experiment. The cells were exposed to different experimental conditions. The 
growth medium was replaced every 2 to 3 days. 
 
GDNF knock-down in the HK-2 cell line  
Our in vitro model of nephrocalcinosis was established by silencing GDNF in HK-2 cells. To 
obtain stable GDNF-silenced cells, five different shRNAs targeting human GDNF 
(NM_000514) purchased from Sigma-Aldrich were used. Each plasmid was separately 
transfected, and a sixth transfection was performed with all five plasmids concurrently, 
according to the manufacturer’s protocol (Mirus Madison). Cells (1.5 x 105 cells per well) 
were transfected with 3 μg of plasmid DNA using the TransIT-LT1 transfection reagent 
(Mirus, Madison). Negative control cells were transfected with an empty pRS plasmid vector 
without shRNA (TR20003), using the same amount of TransIT-LT1 transfection reagent. 
Transfected cells underwent several weeks of selection with 0.75 µg/ml puromycin (Sigma-
Aldrich), and clones with different resistances were obtained from each 29mer shRNA 
targeting GDNF mRNA, as well as from the corresponding negative controls. GDNF mRNA 
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expression was assessed in all the clones using qRT-PCR, as described below. GDNF 
silencing was also assessed at protein level using immunocytochemistry (ICC) with a 
polyclonal GDNF antibody (Santa Cruz Biotechnology). Briefly, ICC staining was performed 
on HK-2 cells fixed with cold methanol for 5 minutes at RT. The cells were then treated with 
3% H2O2 in PBS (pH 7.4) for 15 minutes at RT to remove endogenous peroxidase activity, 
and incubated with 2% normal goat serum (Sigma-Aldrich) for 30 minutes at RT to prevent 
nonspecific antibody binding. Samples were incubated with a rabbit antibody targeting GDNF 
(Santa Cruz Biotechnology) diluted 1:200 in PBS at 4°C overnight. Samples were then rinsed 
with PBS and treated with a DakoCytomation EnVision+System-HRP Labeled Polymer anti-
rabbit antibody (DAKO Corporation) in a humidified chamber at RT for 30 minutes. Signals 
were visualized using the chromogen 3,3-diaminobenzidine-tetrachloride (DAB, DAKO), and 
the cells were counterstained with hematoxylin. The specificity of the immunolabeling was 
confirmed in treated cells without the primary antibody. Slides were analyzed by Diaplan 
light microscope (Leitz). Images were acquired using a Micropublisher 5.0 RTV camera (Q 
Imaging). GDNF protein quantification was performed by morphometric analysis.  
Among the shRNA sequences, the one exhibiting the greatest degree of silencing was chosen 
for all subsequent experiments (shRNA 4E).  
 
 
Osteogenic culture of HK-2 cells 
Wild-type (WT), negative control (cells transfected with an empty vector), and GDNF-
silenced HK-2 (shRNA 4E) cells were cultured in 6-well tissue culture plates (Falcon™ 
Polystyrene Microplates, Thermo Scientific) at a density of 4.5x10
4
 cells per well in 
commercially-available osteogenic medium (NH OsteoDiff medium, Miltenyi Biotec) for 1, 5 
or 15 days. Control conditions were established by culturing cells in DMEM/F12 medium. 
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The osteogenic and the DMEM/F12 medium were both replaced every 2 to 3 days for up to 
15 days. The osteogenic stimulation experiments were run twice.  
 
Detecting and quantifying calcification  
Alkaline phosphatase staining 
Histochemical staining for alkaline phosphatase (ALP), an enzyme involved in bone matrix 
mineralization and an early marker of committed osteogenic cells, was performed with a 
commercially-available kit (SIGMA FAST BCIP/NBT, Sigma-Aldrich). Cells were seeded 
 
in 
chamber slides (4x10
3
 cells/well; Nunc Lab-Tek Chamber Slide system; 8 wells on 
Permanox; Thermo Scientific). After incubation in standard or osteogenic media for 1, 5 or 15 
days, cells were washed twice with PBS and then fixed with pre-chilled methanol for 10 
minutes at RT. After the methanol was removed, cells were washed with deionized H2O, 
treated with SIGMA FAST BCIP/NBT substrate on the cell culture chamber slides, and 
agitated slowly on a plate shaker for 10 minutes at RT. The substrate solution was aspirated, 
and the slides were washed twice with deionized H2O. Slides were mounted in a glycerol and 
water solution, and analyzed under a Leica DMIL LED phase-contrast inverted microscope 
(Leica Microsystems). Images were acquired using a LEICA ICC50W camera. Alkaline 
phosphatase positive signals in the cells were detected as an intense granular blue/purple stain 
and were quantified by morphometric analysis. 
 
Von Kossa staining 
Von Kossa staining was used to detect calcium crystal deposition. Cells were seeded in an 8-
well chamber slide system (4x10
3
 cell/well), incubated in standard (DMEM/F12, 10% HI-
FBS) or osteogenic media for 1, 5 or 15 days, and then washed twice with PBS. They were 
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then fixed in PBS-formalin for 10 minutes. After washing twice with PBS and once with 
water, a 2% silver nitrate solution was added. The slides were exposed to UV light for 30 
minutes and, after rinsing once again with water, sodium thiosulfate (5%) was added for 3 
minutes. The slides were again rinsed in water, then hematoxylin was added for 5 minutes to 
counterstain the nuclei. After rinsing in water for the last time, the slides were mounted in a 
glycerol and water solution and then visualized using a Diaplan light microscope (Leitz). 
To quantify the calcium deposition, images were acquired using a Micropublisher 5.0 RTV 
camera (Q Imaging), and morphometric analysis of the von Kossa staining was performed. 
 
Environmental scanning electron microscopy (ESEM) analysis  
After seeding in 8-well slides (4x10
3
 cells/well) and treatment, cells were washed twice with 
PBS and fixed in methanol for 10 minutes. To assess the chemical composition of the cell 
nodules, ESEM analysis with X-ray fluorescence, coupled with energy-dispersive 
spectroscopy (XRF-EDS), was performed directly on the cells grown on the plastic slides 
using an ELEMENT instrument (EDAX). This method enables the identification of inorganic 
compounds within a biological matrix typically comprising carbon, oxygen, and hydrogen. 
The spectra gathered in the X-ray fluorescence show the peaks of all the elements involved, 
so a semiquantitative measure of the composition of the inclusions can be obtained by 
analyzing the net intensities calculated by the peak integral with background line subtraction.  
 
Detecting and quantifying cell death  
Cell growth and viability assessment 
Cells were plated at 10x10
3
 cells/well in 24-well tissue culture plates (Falcon) and grown to 
50% confluence in culture medium, then the medium was switched to 1% FCS 24 h before 
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the experiments to induce quiescence. A standard (DMEM/F12, 10% HI-FBS) or osteogenic 
(NH OsteoDiff medium, Miltenyi Biotec) medium was added to the cells and changed every 
two days. Proliferation was assessed at different times (on days 0, 1, 2, 3, 4, 7, and 8), by 
means of cell counts and colorimetric assays (24, 25). Briefly, cells were fixed with methanol 
for 10 minutes, then stained with 1% methyl blue in 0.01 M borate buffer (pH 8.5) for 30 
minutes. After repeated washing, the unbound staining solution was eluted with a 1:1 mixture 
of ethanol and 0.1 N HCl, and read at an absorbance of 650 nm. Methyl blue only stains cells 
attached to the substrate before fixation (i.e. living cells), and thus quantifies their 
proliferation and viability.  
 
Simultaneous annexin V-FITC and propidium iodide staining 
Phosphatidylserine externalization was assessed at different time points by measuring annexin 
V and propidium iodide (PI), using a kit from Affymetrix-eBioscience according to the 
manufacturer’s instructions. Briefly, after washing with PBS, the cells were detached using 
trypsin and resuspended at a density of 200-500x10
3
 cells/ml in 100 l annexin binding buffer 
(10 mM HEPES, pH 7.4; 140 mM NaCl, and 2.5 mM CaCl2) containing 5 l of annexin V-
FITC. This mixture was incubated for 10 minutes at RT in the dark, then the cells were 
washed with binding buffer and resuspended in the same buffer containing PI. A minimum of 
1x10
4
 cells were then analyzed, and the apoptotic stages were examined by flow cytometry 
using a CytoFLEX cytometer (Beckman Coulter). AnnexinV-positive/PI-negative and 
annexinV-positive/PI-positive cells were considered in the early and late apoptotic phases, 
respectively. AnnexinV-negative/PI-positive cells were considered necrotic. All cell 
populations were counted together and defined as the total dead cell population. Staurosporine 
(1.0 μM)-treated cells were used as a positive control. 
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Detecting in situ cell death with the TUNEL assay 
DNA fragmentation was assessed using the terminal deoxynucleotidyl transferase-mediated 
dUTP-biotin nick end labeling (TUNEL) assay (TUNEL In Situ Cell Death Detection Kit, 
Roche). Cells were seeded on chamber slides, and cultured for 1, 5 or 15 days in normal and 
osteogenic media (4x10
3
 cells/well). Cell cultures were fixed with 4% formaldehyde in PBS 
for 10 minutes at RT, and permeabilized with 0.1% (vol/vol) Triton X-100 in aqueous 0.1% 
(wt/vol) sodium citrate for 2 minutes on ice. Next, the cells were incubated for 1 h at 37°C 
with a TUNEL reaction mixture comprising a nucleotide mixture in reaction buffer and 
terminal deoxynucleotidyl transferase (TdT). The slides were washed three times with PBS, 
mounted in a glycerol and water solution, examined using a DMI600CS-TCS SP8 
fluorescence microscope (Leica Microsystems), and analyzed with LAS AF software (Leica 
Microsystems). Images were acquired using a DFC365FX camera (Leica Microsystems) and 
morphometric labeling assessment was done. Cells treated with 20.0 U/μl DNase I for 20 
minutes were used as a positive control. 
 
In-Cell Western  
Caspase activation and Runx2 protein  expression  was assessed using In-Cell Western 
analysis as described elsewhere (26). Cells were seeded in a 96-well plate (2x10
3
 cells per 
well) and cultured in standard or osteogenic media for 1, 5 or 15 days. At the end of the 
treatment, cells were immediately fixed with cold methanol for 10 minutes at RT, then 
washed 5 times with 0.1% Triton X-100 in PBS. The samples were blocked in a solution of 
5% milk in PBS containing 0.1% Triton X-100 for 40 minutes at RT with moderate shaking 
followed by incubation with specific primary antibodies (Table 1) overnight at 4°C in a 
humidified chamber. β-tubulin served as an internal control. The plates were washed five 
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times with 0.1% Triton X-100 in PBS and gently agitated for 5 minutes at RT. Next, 
secondary antibody (IRDye 800CW donkey anti-Rabbit, 1:800, from LI-COR, 
Biotechnology, Lincon, NE, USA) was added to each well and incubated in the dark for 60 
minutes at RT with gentle shaking. Finally, the plates were scanned at 800 nm and intensity of 
the labelled proteins was measured using the Odyssey Infrared Imaging System (LI-COR). 
Each experiment was performed in duplicate at least. Negative controls were obtained by 
omitting the primary antibody during the incubation steps, and background values were 
obtained by omitting primary and secondary antibodies. The data are shown as the average ± 
SD. Staurosporine (1.0 μM)-treated cells were used as a positive control. 
 
Quantitative real-time PCR 
Total RNA was extracted from cell cultures at 1, 5 or 15 days using the RNeasy Mini Kit 
(Qiagen Limburg, NL) according to the manufacturer’s instructions, and following the spin 
column protocol. RNA quantity and quality were assessed by spectrophotometric analysis 
using a NanoDrop ND-1000 (Thermo Fischer Scientific Waltham, MA, USA), and by 
capillary electrophoresis using an Agilent 2100 Bioanalyzer (Agilent Technologies Santa 
Clara, CA, USA). RNA samples with an A260/A280 ratio between 1.8-2 and an RNA 
integrity number (RIN) of at least 9 were used for qRT-PCR. A total of 100 ng of total RNA 
was reverse-transcribed in a final volume of 20 l containing 5 mM MgCl2, 1 mM dNTPs, 2.5 
M random hexamers (Applied Biosystems), 1 U/l RNAse inhibitor (Applied Biosystems), 
and 2.5 U/µl MuLV reverse transcriptase (Thermo Fischer Scientific) in a buffer comprising 
50 mM KCl and 10 mM Tris-HCl (pH 8.3). Reactions were performed on a 2720 Thermal 
Cycler (Thermo Fisher Scientific) using the following thermal profile: RT for 10 minutes, 
42°C for 30 minutes, 65°C for 5 minutes, and 4°C for 5 minutes. The primers used are listed 
in Table 2. Primer pairs for the region of interest were designed using Primer3 software ver. 
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4.0 (http://primer3.ut.ee), adopting stringent parameters to ensure successful ampliﬁcation and 
a convenient experimental design. The NCBI Primer-BLAST program was used for in silico 
specificity analysis (www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi), after which each 
primer pair was validated. Microchip electrophoresis on an Agilent 2100 Bioanalyzer, Sanger 
sequencing and melting curve analyses were used to measure the specificity of the PCR 
reactions. Amplification curves were established for all the primers and resulted in an 85% 
efficiency, at least. qRT-PCR was performed using an iCycler Thermal Cycler (Bio-Rad 
Hercules, CA, USA) and SYBR Green I technology with iQ
TM
 SYBR Green Master Mix 
(Bio-Rad) in a final volume of 20 µl final volume containing 1 µl of reverse-transcribed 
cDNA template. An appropriate primer concentration (0.3 µM) was used, and the annealing 
temperatures are listed in Table 1. Data analysis was performed using the ΔΔCt method, 
normalizing the data to two different housekeeping genes (GAPDH and HPRT1) according to 
the MIQE guidelines (27). The normalized relative quantification (nRQ) was calculated as 
2
−ΔΔCt
. A melting curve analysis was performed to identify any nonspecific amplification 
products. The results were obtained from two separate experiments performed in triplicate.  
 
Morphometric analysis 
Morphometric analysis was performed by Image-Pro Plus software (Media Cybernetics). For 
each experimental sample, a maximum of 15 images at 200X or 400X magnification was 
analyzed. Signals were acquired for all the images with the same brightness and contrast 
characteristics from three different slides and the quantity was expressed as the percentage of 
the mean area covered by pixels (28, 29). 
 
Statistical analysis 
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Data are presented as means ± SDs. Multiple group means were compared using ANOVA 
with a between-within design and Bonferroni’s correction. Data from the morphometric 
analysis were examined using a non-parametric test (the Mann-Whitney U test), and statistical 
significance was established with the Primer software (McGraw-Hill). A p value of less than 
0.05 was considered statistically significant. 
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RESULTS 
An osteogenic-like process occurred in the calcification of GDNF-silenced HK-2 cells 
In GDNF-silenced HK-2 cells, gene knock-down resulted in an approximately 70% reduction 
in GDNF transcript and 60% in protein levels (Figure 1). There was a multilayered growth in 
both the control and the silenced cells cultured in osteogenic conditions, with cells retracting 
from some areas and grouping into multicellular aggregates or nodules. The silenced cells 
also exhibited many more nodules with dense deposits than the control cells, and this became 
increasingly evident over time (Figure 2).  
Notably, this distinct “hill and valley” morphology developed in parallel with the deposition 
of calcium aggregates (as revealed by von Kossa staining), which was detectable already after 
5 days of culture, and increased substantially over 15 days (Figure 3). When the von Kossa 
staining was measured using morphometric analysis, there was significantly more calcium 
deposition in the silenced than in the control cells at 5 (p<0.05) and 15 days (p<0.005 vs WT; 
p<0.01 vs Negative control) (Figure 3 B). No calcium deposition was seen in the control or 
silenced cells cultured under standard conditions (Figure 3 A). ESEM analysis revealed that 
the granular concretions ranged from 1.0 to 40 m in diameter, and contained an abundance 
of calcium and phosphate (Figure 4). The concomitant presence of calcium and phosphate 
suggests Ca2PO4 precipitation in the nodules. Much smaller amounts of these aggregates were 
also seen in the WT and control cells cultured in osteogenic conditions (Figure 4 B). 
The gene expression of osteoblastic markers such as Runx2 (an early osteogenic 
programming gene) and osteopontin and osteonectin (later osteogenic programming genes), 
was measured over the course of osteogenic induction to see if Ca2PO4 deposition was related 
to an osteogenic-like process. We detected a significant increase of Runx2 expression at days 
1 and 5 compared to day 15 (Figure 5 A). However, no difference between GDNF-silenced 
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HK-2 cells and control cells was found.  A difference between control and silenced cells was 
instead demonstrated by evaluating Runx2 expression at protein level by In-Cell Western. In 
fact, Runx2 was significantly higher in silenced cells than in control cells at 5 days (p<0.05 vs 
Negative Control p<0.005 vs WT).   
 Figure 5 B shows that the osteonectin/osteopontin ratio was significantly higher in the 
GDNF-silenced HK-2 cells than in the control cells. The highest osteonectin/osteopontin ratio 
was recorded after 5 days (p<0.005 shRNA 4E vs Negative Control; p<0.01 shRNA 4E vs 
WT).  
On cytochemical examination of ALP activity, GDNF-silenced cells showed a significant 
higher positive signal than control cells after 15 days of treatment with osteogenic medium 
(p<0.005 vs Negative Control and WT) (Figure 5 C). Positive signals were detected 
predominantly around the nodules and were observed also in some of the control cells. 
 
Massive cell death occurred in the calcified nodules of GDNF-silenced HK-2 cells 
Cell proliferation was analyzed first. Cells were monitored for 1 to 8 days, and control cells 
exhibited a similar growth in the standard and osteogenic media, with a gradual time-
dependent increase in their growth (Figure 6). At each time point on the growth curve, 
GDNF-silenced HK-2 cells exhibited significantly less proliferation than control cells 
(p<0.005), pointing to the role of GDNF as a survival factor for renal tubular cells too. The 
silenced cells in osteogenic medium did start to grow after 4 to 7 days of culture, however, 
albeit more slowly than the control cells (p<0.005) (Figure 6).  
Then the cell death process was examined and quantified by means of a simultaneous staining 
with annexin V-FITC and PI, which enabled us to discriminate between apoptotic and non-
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apoptotic cell death. Under osteogenic conditions, there was an overall increase in the cell 
death rate at 15 days compared with the rate at 5 days, in both control and silenced cells 
(Figure 7 A), but the difference was greater in the latter (p<0.05). Phosphatidylserine 
externalization usually occurs in the inner leaflet of the plasma membrane, and is one of the 
earliest signs of apoptosis, preceding DNA fragmentation and membrane blebbing. After 5 
days in osteogenic medium, there was a predominant population in the early apoptotic phase 
(annexinV-positive/PI-negative), which was significantly greater in the silenced than in the 
control cells (p<0.05). (Figure 7 B). After 15 days in osteogenic medium, there were two 
predominant types of dead cell population, one only PI-positive (necrotic cells), the other was 
annexinV-positive and PI-positive (cells in late apoptosis). This latter population was 
significantly more evident in the silenced than in the control cells (p<0.05) (Figure 7 B). The 
various phases of the process appeared to have been completed within the time window 
considered, indicating a transition from early to advanced or late apoptosis. In standard 
culture conditions, the dead cells were more numerous among the silenced cells, but they 
were mainly in the early phase of apoptosis (data not shown). These results again point to 
GDNF acting as a survival factor for the renal tubular cells. 
One of the most common hallmarks of apoptosis is DNA fragmentation, so DNA content in 
the GDNF-silenced HK-2 cells was analyzed by TUNEL assay. While no positive staining 
was observed at 5 days, several nodules had positively stained nuclei in the silenced cells after 
15 days of culturing, meaning that these cells were probably apoptotic (Figure 8). There were 
few positive nodules in the control cells but the signal was less intense, and the number of late 
apoptotic cells was significantly lower than in the silenced cells (p<0.05), while there were 
more necrotic cells (Figure 7 B). No staining was apparent in any areas/cells around the 
nodules, or in cells cultured in standard conditions (data not shown). Taken together, these 
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findings indicate that the presence of apoptotic bodies in the nodules was associated with the 
calcification process.   
 
The death process in GDNF-silenced HK-2 cells is caspase-independent 
Activation of the apoptotic process was examined by measuring BCL2 (anti-apoptotic) and 
BAX (pro-apoptotic) gene expression using qRT-PCR. Silenced cells cultured in the 
osteogenic medium showed a significantly higher BCL2 expression at 1 (p<0.005) and 5 
(p<0.05) days than the control cells, while BAX expression increased over time but no more 
than in the control cells (Figure 9).  
The onset of apoptosis is characterized by caspase-3, -6, -7 and -9 activation in the cytosol.  
In-Cell Western analysis was performed on the control and GDNF-silenced cells grown in 
osteogenic medium to detect any presence of activated caspases. The levels of cleaved 
caspase-9 (an initiator caspase), and cleaved caspase-3, -6 and -7 (effector caspases) were 
measured, and so were those of cleaved nuclear protein poly- (ADP-ribose) polymerase 
(PARP), which is a caspase substrate. Silenced cells exhibited significantly lower caspase and 
PARP levels than control cells at both 5 and 15 days (Figure 10 A).  
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DISCUSSION 
We previously reported that an unexpected calcification process spontaneously occurred in 
primary papillary cells obtained from the kidney biopsy of a patient with MSK and interstitial 
nephrocalcinosis who harbors a GDNF gene mutation (8). We also demonstrated that 
culturing GDNF-silenced HK-2 cells in osteogenic medium induced Ca2PO4 deposition and 
the expression of osteoblast differentiation markers (8). Further investigations were 
warranted, however, to see whether GDNF down-regulation directly causes or contributes to 
the osteogenic-like calcification process seen in primary renal and HK-2 cells.  
This study sought to ascertain whether down-regulating GDNF could lead to cell death and 
thus trigger a process of nephrocalcinosis under certain conditions. GDNF is known to have  
survival-supporting properties in neurons (30). In the kidney, it was found to act in an 
autocrine manner, supporting podocyte survival (31). The important protective role of GDNF 
in the apoptotic process is supported by the literature regarding not only the kidney (31-33), 
but also the bowel. In Crohn's disease, for instance, GDNF protects the enteric glial cells of 
the intestinal mucosa against apoptosis, thus preserving its integrity and function (34). GDNF 
down-regulation might therefore conceivably trigger calcification by favoring cell death. 
A previously-adopted in vitro experimental model of GDNF down-regulation in HK-2 cells 
was used here to elucidate the mechanisms underlying the calcification process in renal cells 
(8). GDNF expression levels were monitored at various times during osteogenic induction and 
under standard conditions, and the results indicated that GDNF expression was always 
significantly lower in silenced than in control cells (data not shown).  
The occurrence of an osteogenic-like process in our model, which began after 5 days of 
culture, was confirmed by the early Runx2 upregulation and by the increase in the 
osteonectin/osteopontin expression ratio. This observation is in keeping with findings 
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suggesting Runx2 triggers the expression of major bone matrix genes during early stages of 
osteoblasts differentiation, and its overexpression stops in the later stage and is not essential 
for maintenance of these gene expressions in mature osteoblasts (35, 36). Osteonectin is 
known to promote the formation of mineral deposits (37), whereas osteopontin is considered a 
powerful inhibitor of crystal formation (38-40). Our results indicate that the balance between 
these latter pro- and anti-osteogenic factors in the shRNA 4E cells favored an osteogenic 
process. The quantification of ALP activity, a later osteoblast differentiation marker (41), 
further confirmed the osteoblastic-like phenotype of silenced cells cultured in osteogenic 
medium. Thus, the pattern of expression of both Runx2, and osteonectin/osteopontin, as well 
as ALP confirm that an active osteogenic-like process occurred in the GDNF-silenced HK-2 
cells in osteogenic culture, inducing calcification that was detectable already after 5 days of 
culture, and increased considerably over 15 days. This calcification was localized exclusively 
in the nodules and/or cell aggregates. These results further support our hypothesis of a 
procalcifying stimulus of GDNF downregulation (8).  
Having ascertained that GDNF massively favored the Ca2PO4 deposition process in our in 
vitro model of nephrocalcinosis, we investigated whether cell death had occurred under the 
same conditions. The slow proliferation of silenced cells in the standard and osteogenic media 
appeared to support the primary hypothesis of this work, i.e. that GDNF down-regulation may 
be related to cell death phenomena, and potentially to apoptosis. Different methods were used 
to investigate this issue, which shed light on how the cell death process occurred.  
Both late apoptotic and necrotic cells were amply represented in the control and silenced cells 
cultured in osteogenic medium for 15 days. In the GDNF-silenced cell population, the 
apoptotic cells were found in abundance and exclusively in the nodules where calcium and 
phosphate precipitated, suggesting that they served as nuclei for calcification.  
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The increase in annexin V-positive cells at 15 days, associated with PI-positive staining, 
might be due not only to the phosphatidylserine externalization associated with late phases of 
apoptosis, but also to the loss of membrane integrity characteristic of secondary necrosis (i.e. 
necrosis after apoptosis). In fact, cells with impaired membranes are also labeled with annexin 
V-FITC, which enters the cells and stains the internal surface of the plasma membrane, where 
phosphatidylserine is normally found. Some Authors therefore suggest that concurrently 
assessing both probes only enables us to distinguish between early-stage apoptotic cells 
(annexinV-positive/PI-negative) and necrotic cells (annexinV-positive/PI-positive, and 
annexinV-negative/PI-positive) (42, 43). In other words, the annexinV-positive/ PI-positive 
cells may be in a later stage of apoptosis and/or undergoing secondary necrosis. 
Necrosis causes DNA cleavage too, though such cleavage is not characteristically 
internucleosomal. TUNEL assay may not distinguish the internucleosomal DNA cleavage of 
apoptosis from the DNA cleavage of necrosis (44, 45). The present results nonetheless 
confirm that many cells within the nodule underwent cell death after between 5 and 15 days 
of osteogenic culture. They also suggest that both necrotic and apoptotic cells may serve as 
nuclei for calcification.  In fact, the osteogenic culture of GDNF-silenced cells induced cell 
death in a time-dependent manner, and the apoptotic process was completed by day 15, when 
the quantity of calcified nodules was at its highest. 
During the apoptotic process, mitochondrial outer membrane permeabilization is regulated by 
various proteins, such as those encoded by the mammalian BCL2 family of genes (46, 47), 
which can directly promote or inhibit apoptosis. BCL2 protein inhibits the formation of a pore 
formed by BAX, which promotes apoptosis by competing with BCL2. BAX and BCL2 were 
therefore selected as pro- and anti-apoptotic markers, respectively, for our gene expression 
study. While a temporal increase in BAX was observed under osteogenic conditions (with no 
difference between the silenced and control cells), there was a surprisingly and significantly 
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higher level of BCL2 in the GDNF-silenced cells after 1 and 5 days of culture. BCL2 is an 
anti-apoptotic protein that regulates apoptosis at mitochondrial level by maintaining the 
integrity of the mitochondrial membrane and blocking the release of apoptosis factors such as 
cytochrome C from the mitochondria to the cytoplasm, thereby preventing the activation of 
the caspase cascade. Consistently, we found a lower quantity of cleaved caspases in the 
GDNF-silenced cells than in the control cells. The high BCL2 expression in the former cells 
probably inhibits caspase cleavage and subsequent activation.  
These findings in the GDNF-silenced cells appear to contrast with the flow cytometry and 
TUNEL results, which confirmed a massive presence of cells in the late phase of apoptosis. 
Though they were undergoing apoptosis, the control cells cultured in osteogenic conditions 
did not display BCL2 up-regulation or caspase down-regulation, indicating that the apoptotic 
process underway was caspase-dependent. It is worth adding that calcification was less 
pronounced in the control cells that underwent a quantitatively and qualitatively different cell 
death process: a caspase-independent cell death seemed to be peculiar to GDNF-silenced cell 
calcification. These cells also underwent a process of necrosis. Collectively, these data seem 
to indicate that - instead of preventing cell death as such - inhibiting postmitochondrial 
protease activation causes a shift from the apoptotic to another mode of programmed cell 
death.  
In an in vivo model of vascular calcification, cell death proved to be caspase-dependent 
apoptosis (48). During osteoblastic differentiation of human mesenchymal cells in vitro, both 
necrotic and apoptotic cells were found to serve as nuclei for calcification (49). In our in vitro 
model of renal calcification, the cell death process was caspase-independent. Several types of 
programmed cell death in which caspase activation plays no part (50, 51) have been described 
so far, including: those that involve no DNA fragmentation, such as autophagy-related cell 
death (52) and paraptosis (53, 54); and those that lead to a regulated form of necrosis, or 
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necroptosis (55,56), which is considered an adaptive response to ensure the elimination of 
damaged cells and protect the well-being of the organism as a whole. Necroptosis is activated 
in a programmed fashion similar to apoptosis, but morphologically exhibits the hallmarks of 
necrosis. The programmed cell death seen in our model could be classified as necroptosis, as 
its characteristics were intermediate between apoptosis and necrosis. The cell death seen in 
our model was clearly caspase-independent, however. Several necroptotic pathways have 
recently been discovered in renal cells, depending on the initial stimulus, such as calcium 
crystals (57), cadmium (58), and TNF-alpha (59), or on the type of acute kidney injury (60-
62). 
Our evidence of the effect of GDNF silencing on cell death is consistent with reports from 
other authors (63, 64), who found no mitochondrial pathway activation in GDNF-deprived 
sympathetic neurons. Cytochrome c was not released from the mitochondria into the cytosol; 
and BAX and caspases-9 and -3 were not involved in the cell death process.  Many cells in 
which the main mitochondrial death pathway is genetically or pharmacologically disabled can 
still die via an alternative pathway, which is often caspase-independent (53, 64-68).  
The undeniable complexity of the mechanisms involved in cell death has shown that, under 
certain conditions, markers of apoptosis and necrosis may be found simultaneously, indicating 
that more than one cell death mechanism can be activated at the same time (69). While there 
may be signs of different cell death pathways being involved, the fastest and most effective 
pathway is often predominant (70). In support of our data, studies focusing on the process of 
osteoblast maturation (a typical osteogenic process) have provided no direct evidence of the 
activation of caspase-dependent apoptotic processes accompanying osteogenesis (71-73).  
In conclusion, GDNF was confirmed as an adaptive survival factor, and its alteration appears 
to have a key role in nephrocalcinosis. The findings emerging from the present study indicate 
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that GDNF down-regulation can trigger apoptosis in human renal tubular cells and, under 
certain environmental conditions (e.g. in an osteogenic medium), this can strongly facilitate 
calcium phosphate deposition. Our results also suggest, however, that this apoptotic process is 
caspase-independent. Further studies are needed to better define the necroptosis signaling 
underlying the observed programmed cell death phenomenon.  
We are tempted to speculate that, if cell death is an important event in the pathogenesis of 
renal ectopic calcification, any damage that shifts the balance between cell survival and cell 
death towards the latter could lead (in conjunction with a particular renal milieu) to the 
phenomenon of interstitial nephrocalcinosis. 
It has long been known that ectopic calcification follows necrosis. In the kidney, cortical 
nephrocalcinosis (a rare condition usually resulting from severe destructive disease in the 
cortex) has been attributed to the presence of necrotic tubular cells (18). To our knowledge, 
no attention has been paid as yet to the role of cell death in the more common interstitial 
nephrocalcinosis. 
 
 
CLINICAL PERSPECTIVES 
We know that ectopic calcification may follow necrosis. In the kidney, cortical 
nephrocalcinosis (a rare condition usually resulting from severe destructive disease in the 
cortex) has been attributed to the presence of necrotic tubular cells. To our knowledge, no 
attention has been paid as yet to the role of cell death in the more common interstitial 
nephrocalcinosis. In this study, we demonstrated that programmed cell death played an 
important part in the renal cell calcification process in an in vitro model of nephrocalcinosis. 
We speculate that, if cell death is an important event in the pathogenesis of renal calcification, 
any damage that shifts the balance between cell survival and cell death towards the latter 
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could lead (in conjunction with a particular renal milieu) to the phenomenon of interstitial 
nephrocalcinosis. The discovery of alternative, caspase-independent cell death pathways 
demands the search for new strategies - not only for treating disorders such as cancer or  
ischemic and degenerative diseases, but also for nephrocalcinosis and/or nephrolithiasis. 
 
 
  
27 
 
ACKNOWLEDGMENTS 
We would like to thank Valentina Masola of the Department of Biomedical Science for her 
technical assistance with the GDNF gene silencing, and Claudia Maria Radu of the 
Department of Medicine - DIMED for helping us to establish the technical conditions for flow 
cytometry.  
 
DECLARATIONS OF INTEREST 
The authors have no conflicts of interest to disclose. 
 
FUNDING INFORMATION 
This study was supported by a grant (CPDA085494) from the University of Padua. 
 
AUTHOR CONTRIBUTION STATEMENT  
GP planned and conducted the experiments, analyzed the data, and wrote the manuscript. FQ, 
MC, LG, RC and LT conducted the experiments and analyzed the data. CF performed the 
ESEM analyses. DDP analyzed the data and revised the manuscript. FA coordinated and 
planned the experiments and wrote the manuscript. 
  
28 
 
REFERENCES 
1. Sayer JA, Carr G, Simmons NL. Nephrocalcinosis: molecular insights into calcium 
precipitation within the kidney. Clin Sci (Lond). 2004;106: 549–61 
2. Vervaet BA, Verhulst A, D’Haese PC, De Broe ME. Nephrocalcinosis: new insights 
into mechanisms and consequences. Nephrol Dial Transplant Rev. 2009;24: 2030–5. 
3. Gambaro G, Trinchieri A. Recent advances in managing and understanding 
nephrolithiasis/nephrocalcinosis. F1000Res. 2016;5:1-8. 
4. Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest. 2003;111: 
602–5. 
5. Khan SR. Nephrocalcinosis in animal models with and without stones. Urol Res. 
2010;38(6):429-38 
6. Gambaro G, D'Angelo A, Fabris A, Tosetto E, Anglani F, Lupo A. Crystals, Randall’s 
plaques and renal stones: do bone and atherosclerosis teach us something? J Nephrol. 
2004;17: 774–7 
7. Torregrossa R, Anglani F, Fabris A, Gozzini A, Tanini A, Del Prete D, et al. 
Identification of GDNF gene sequence variations in patients with medullary sponge 
kidney disease. Clin J Am Soc Nephrol. 2010;5(7):1205-10. 
8. Mezzabotta F, Cristofaro R, Ceol M, Del Prete D, Priante G, Familiari A, et al. 
Spontaneous calcification process in primary renal cells from a medullary sponge 
kidney patient harbouring a GDNF mutation. J. Cell. Mol. Med. 2015;19: 889-902. 
9. Kirsch T. Determinants of pathological mineralization. Curr Opin Rheumatol. 
2006;18: 174–180.  
10. Hashimoto S, Ochs RL, Rosen F, Quach J, McCabe G, Solan J, et al. Chondrocyte-
derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci 
USA. 1998;95: 3094–3099.  
29 
 
11. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and 
related proteins in different stages of human atherosclerotic plaques. Circulation. 
1998;97: 2307–2315.  
12. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. 
Apoptosis regulates human vascular calcification in vitro: evidence for initiation of 
vascular calcification by apoptotic bodies. Circ Res. 2000;87: 1055–1062.  
13. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological 
mechanisms and clinical implication. Circ Res. 2006;99:1044-1059. 
14. Rong S, Zhao X, Jin X, Zhang Z, Chen L, Zhu Y, et al. Vascular calcification in 
chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism 
involving the Wnt/β-catenin pathway. Cell Physiol Biochem. 2014;34(6):2049-60. 
15. Leopold JA. Vascular calcification: Mechanisms of vascular smooth muscle cell 
calcification. Trends Cardiovasc Med. 2015;25(4):267-74.  
16. Cliff WJ. The aortic tunica media in aging rats. Exp Mol Pathol. 1970;13:172–189. 15.  
17. Klotz O. Studies upon calcareous degeneration: I. The process of pathological 
calcification. J Exp Med. 1905;7: 633–674.  
18. Rockley GJ. A case of renal cortical necrosis with dystrophic calcification 
demonstrated at the Postgraduate Medical School of London. Br Med. J 1965;2: 633–
636 
19. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate 
development and biomineralization. Front Biosci. 2005;10: 822–837. 
20. Drabek K, van de Peppel J, Eijken M, van Leeuwen JP. GPM6B regulates osteoblast 
function and induction of mineralization by controlling  cytoskeleton and matrix 
vesicle release. J Bone Miner Res. 2011;26: 2045–2051.  
30 
 
21. Boskey AL. Biomineralization: conflicts, challenges, and opportunities. J Cell 
Biochem Suppl. 1998;30-31: 83–91. 
22. Wuthier RE, Lipscomb GF. Matrix vesicles: structure, composition, formation and 
function in calcification. Front Biosci. 2012;17: 2812–2902. 
23. Kirsch T, Wang W, Pfander D. Functional differences between growth plate apoptotic 
bodies and matrix vesicles. J Bone Miner Res. 2003;18: 1872–1881. 
24. Oliver MH, Harrison NK, Bishop JE, Cole PJ, Laurent GJ. A rapid and convenient 
assay for counting cells cultured in microwell plates: application for assessment of 
growth factors. J Cell Sci. 1989;92(Pt 3):513-518.  
25. Musacchio E, Priante G, Budakovic A, Baggio B. Effects of unsaturated free fatty 
acids on adhesion and on gene expression of extracellular matrix macromolecules in 
human osteoblastlike cell cultures. Connect Tissue Res. 2007;48(1):34-38. 
26. Gianesello L, Priante G, Ceol M, Radu CM, Saleem MA, Simioni P, Terrin L, Anglani 
F, Del Prete D. Albumin uptake in human podocytes: a possible role for the cubilin-
amnionless (CUBAM) complex. Sci Rep. 2017;7(1):13705. 
27. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE 
guidelines: minimum information for publication of quantitative Real-Time PCR 
experiments. Clin Chem. 2009;55(4): 611-622. 
28. Del Prete D, Ceol M, Anglani F, Vianello D, Tiralongo E, Valente M, et al. Early 
activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies. 
Experimental and Molecular Pathology. 2009;87:141–145. 
29. Ceol M, Tiralongo E, Baelde HJ, Vianello D, Betto G, Marangelli A, et al. 
Involvement of the Tubular ClC-Type Exchanger ClC-5 in Glomeruli of Human 
Proteinuric Nephropathies. PLoS One. 2012;7(9): e45605. 
31 
 
30. Tovar-Y-Romo LB, Ramírez-Jarquín UN, Lazo-Gómez R, Tapia R. Trophic factors as 
modulators of motor neuron physiology and survival: implications for ALS therapy. 
Front Cell Neurosci. 2014;8:61. 
31. Tsui CC, Shankland SJ, Pierchala BA. Glial cell line-derived neurotrophic factor and 
its receptor ret is a novel ligand-receptor complex critical for survival response during 
podocyte injury. J Am Soc Nephrol. 2006;17: 1543–52. 
32. Orth SR, Ritz E, Suter-Crazzolara C. Glial cell line-derived neurotrophic factor 
(GDNF) is expressed in the human kidney and is a growth factor for human mesangial 
cells. Nephrol Dial Transplant. 2000;15(5):589-95. 
33. Shi H, Patschan D, Dietz GP, Bähr M, Plotkin M, Goligorsky MS. Glial cell 
linederived neurotrophic growth factor increases motility and survival of cultured 
mesenchymal stem cells and ameliorates acute kidney injury. Am J Physiol. Renal 
Physiol. 2008;294(1):F229-35. 
34. Steinkamp M, Gundel H, Schulte N, Spaniol U, Pflueger C, Zizer E, et al. GDNF 
protects enteric glia from apoptosis: evidence for an autocrine loop. BMC 
Gastroenterology. 2012;12:16. 
35. Komori T. Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol. 
2010; 658:43-49. 
36. Jiahai Xu, Zhanghua Li, Yudong Hou, Weijun Fang. Potential mechanisms underluing 
the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells. Am J 
Transl Res. 2015;7:2527-2535. 
37. Kirkham GR, Cartmell SH. Genes and proteins involved in the regulation of 
osteogenesis. In: Ashammakhi N, Reis R, Chiellini E, eds. Topics in tissue 
engineering. 2007;1–22. 
32 
 
38. Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, et al. 
Osteopontin  is a critical inhibitor of calcium oxalate crystal formation and retention in 
renal tubules. J Am Soc Nephrol. 2003;14:139–147. 
39. McKe MD, Nanci A, Khan SR. Ultrastructural immunodetection of osteopontin  and 
osteocalcin as major matrix components of renal calculi. J Bone Miner Res. 1995;10: 
1913–1929. 
40. Hoyer JR, Asplin JR, Otvos L. Phosphorylated osteopontin peptides suppress 
crystallization by inhibiting the growth of calcium oxalate crystals. Kidney Int. 
2001;60: 77–82. 
41. Qi H, Aguiar DJ, Williams SM, La Pean A, Pan W, Verfaillie CM, et al. Identification 
of genes responsible for osteoblast differentiation from human mesodermal progenitor 
cells. Proc Natl Acad Sci USA.  2003;100:3305–3310. 
42. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. 
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells 
undergoing apoptosis. Blood. 1994;84(5):1415-1420. 
43. Sgonc R, Gruber J. Apoptosis detection: an overview. Exp Gerontol. 1998;33(6):525-
533. 
44. Trichonas G, Murakami Y, Thanos A, Morizane Y, Kayama M, Debouck CM, et al. 
Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor 
necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci U S A. 
2010;107: 21695–21700.  
45. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-
Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate 
among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 
1995;21: 1465–1468.  
33 
 
46. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the 
mitochondria in apoptosis. Genes Dev. 1999;13(15):1899-1911 
47. Festjens N, van Gurp M, van Loo G, Saelens X, Vandenabeele P. Bcl-2 family 
members as sentinels of cellular integrity and role of mitochondrial intermembrane 
space proteins in apoptotic cell death. Acta Haematol. 2004;111(1-2):7-27. 
48. Mune S, Shibata M, Hatamura I, Saji F, Okada T, Maeda Y, et al. Mechanism of 
phosphate-induced calcification in rat aortic tissue culture: possible involvement of 
Pit-1 and apoptosis. Clin Exp Nephrol. 2009;13(6):571-577 
49. Fujita H, Yamamoto M, Ogino T, Kobuchi H, Ohmoto N, Aoyama E, et al. Necrotic 
and apoptotic cells serve as nuclei for calcification on osteoblastic differentiation of 
human mesenchymal stem cells in vitro  . Cell Biochem Funct. 2014;32(1):77-86 
50. Bröker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin 
Cancer Res. 2005;11(9):3155-3162. 
51. Lockshin RA, Zakeri Z. Caspase-independent cell death? Oncogene 2004;23:2766-
2773. 
52. Lee C Y, Baehrecke E H. Steroid regulation of autophagic programmed cell death 
during development. Development. 2001;128:1443–1455. 
53. Sperandio S, de Belle I, Bredesen D E. An alternative, nonapoptotic form of 
programmed cell death. Proc Natl Acad Sci USA. 2000;97:14376–14381.  
54. Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW. Nonapoptotic 
neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl 
Acad Sci USA. 2000;97:8093–8097. 
55. Dana E. Christofferson and Junying Yuan. Necroptosis as an alternative form of 
programmed cell death. Curr Opin Cell Biol. 2010;22(2): 263–268. 
34 
 
56. Weinlich R, Oberst A,  Beere H M, Green DR. Necroptosis in development, 
inflammation and disease. Nature Reviews Molecular Cell Biology. 2017;18: 127–136. 
57. Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, et al. 
Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun. 
2016;7:10274. 
58. Gang Liu, Hui Zou, Tongwang Luo, Mengfei Long, Jianchun Bian, Xuezhong Liu, et 
al. Caspase-Dependent and Caspase-Independent Pathways Are Involved in 
Cadmium-Induced Apoptosis in Primary Rat Proximal Tubular Cell Culture. PLoS 
One. 2016;11(11): e0166823.  
59. Al-Lamki RS, Lu W, Manalo P, Wang J, Warren AY, Tolkovsky AM, et al. Tubular 
epithelial cells in renal clear cell carcinoma express high RIPK1/3 and show increased 
susceptibility to TNF receptor 1-induced necroptosis. Cell Death Dis. 
2016;30;7(6):e2287.  
60. Liang X, Chen Y, Zhang L, Jiang F, Wang W, Ye Z, et al. Necroptosis, a novel form 
of caspase-independent cell death, contributes to renal epithelial cell damage in an 
ATP-depleted renal ischemia model. Mol Med Rep. 2014;10(2):719-724.  
61. Zhu Y, Cui H, Xia Y, Gan H. RIPK3-Mediated Necroptosis and Apoptosis 
Contributes to Renal Tubular Cell Progressive Loss and Chronic Kidney Disease 
Progression in Rats. PLoS One. 2016;11(6):e0156729.  
62. Martin-Sanchez D, Poveda J, Fontecha-Barriuso M, Ruiz-Andres O, Sanchez-Ni˜no 
MD, Ruiz-Ortega M, et al. Targeting of regulated necrosis in kidney disease. 
Nefrologia. 2017; http://dx.doi.org/10.1016/j.nefro.2017.04.004. 
63. Yu LY, Jokitalo E, Sun YF, Mehlen P, Lindholm D, Saarma M, et al. GDNF-deprived 
sympathetic neurons die via a novel nonmitochondrial pathway. The Journal of Cell 
Biology.  2003;987–997 
35 
 
64.  Yu LY, Saarma M, Arumäe U.. Death receptors and caspases but not mitochondria 
are activated in the GDNF- or BDNF-deprived dopaminergic neurons. J Neurosci. 
2008;28(30):7467–7475 
65. Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan CY, Rakic P. Programmed 
cell death of developing mammalian neurons after genetic deletion of caspases. J 
Neurosci. 2001;21(13):4752-4760. 
66. Yaginuma H, Shiraiwa N, Shimada T, Nishiyama K, Hong J, Wang S, et al. Caspase 
activity is involved in, but is dispensable for, early motoneuron death in the chick 
embryo cervical spinal cord. Mol Cell Neurosci. 2001;18(2):168-182. 
67. Zaidi AU, D'Sa-Eipper C, Brenner J, Kuida K, Zheng TS, Flavell RA, et al. Bcl-X(L)-
caspase-9 interactions in the developing nervous system: evidence for multiple death 
pathways. J Neurosci. 2001;21(1):169-175. 
68. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, et al. Apoptosis 
initiated by Bcl-2-regulated caspase activation independently of the cytochrome 
c/Apaf-1/caspase-9 apoptosome. Nature. 2002;419(6907):634-637. 
69. Unal-Cevik I, Kilinç M, Can A, Gürsoy-Ozdemir Y, Dalkara T. Apoptotic and 
necrotic death mechanisms are concomitantly activated in the same cell after cerebral 
ischemia. Stroke. 2004;35(9):2189-2194. 
70. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. 
Cell Death Differ. 2001;8(6):569-581. 
71. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and 
implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 
2000;2:115-137. 
36 
 
72. Norsgaard H, Clark BF, Rattan SI. Distinction between differentiation and senescence 
and the absence of increased apoptosis in human keratinocytes undergoing cellular 
aging in vitro. Exp Gerontol. 1996;31:563-570. 
73. Adamova E, Janeckova E, Kleparnik K, Matalova E. Caspases and osteogenic 
markers-in vitro screening of inhibition impact. In Vitro Cell Dev Biol Anim. 
2016;52(2):144-148. 
 
 
37 
 
TABLES  
Target Clone Host Manufacturer Code dilution  
Cleaved Caspase-3 
(Asp175) 
5A1E rabbit 
Cell Signaling 
Technology 
CST-9664 1:1,000 
Cleaved Caspase-9 
(Asp330) 
D2D4 rabbit 
Cell Signaling 
Technology 
CST-7237 1:1,000 
Cleaved Caspase-9 
(Asp315) 
- rabbit 
Cell Signaling 
Technology 
CST-9505 1:1,000 
Cleaved PARP 
(Asp214) 
D64E10 rabbit 
Cell Signaling 
Technology 
CST-5625 1:1,000 
Runx2/CBFA1 - rabbit Novus Biologicals NBP1-77461 1:50 
β-Tubulin H235 rabbit 
Santa Cruz 
Biotechnology 
sc-9104 1:50 
 
Table 1. Primary antibodies and dilutions used for in-cell Western analyses. 
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PRIMERS 
 
NUCLEOTIDE SEQUENCE 
 
T annealing 
(°C) 
 
NCBI reference 
sequence 
 
Efficiency 
(%) 
GAPDH Fw 
GAPDH Rev 
GAAGGTGAAGGTCGGAGT 
TGGCAACAATATCCACTTTACCA 
60 NM_17851.1 99.0 
HPRT1 Fw 
HPRT1 Rev 
CCTGGCGTCGTCATTAGTGA 
TCTCGAGCAAGACGTTCAGT 
60 NM_000194.2 97.8 
Osteonectin Fw 
Osteonectin Rev 
CCTGGATCTTCTTTCTCCTTTGC 
ATCAGGCAGGGCTTCTTGCT 
60 NM_001309443.1 97.9 
Osteopontin Fw 
Osteopontin Rev 
CGAGACCTGACATCCAGTACC 
GATGGCCTTGTATGCACCATTC 
62 NM_001251830.1 96.2 
Runx2 Fw 
Runx2 Rev 
CATTTCAGATGATGACACTGCC 
GGATGAAATGCTTGGGAACTG 
62 NM_001024630.3 95.2 
BAX Fw 
BAX Rev 
GCCGTGGACACAGACTCC 
AAGTAGAAAAGGGCGAAACC 
60 NM_001291428.1 91.2 
BCL2 Fw 
BCL2 Rev 
TCATGTGTGTGGAGAGCGTCAA 
CAGCCAGGAGAAATCAAACAGAGG 
60 NM_000633.2 88.9 
GDNF Fw 
GDNF Rev 
GGCTATGAAACCAAGGAGGAACTG 
TCCACCACCCTGTTGCTGTA 
64 NM_000514 98.7 
 
Table 2. Primer sequences used in qRT-PCR analyses. 
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FIGURES and LEGENDS 
 
 
Figure 1. GDNF knock-down in an HK-2 cell line. (A) GDNF protein detected using 
immunocytochemistry in wild-type (WT), negative control and silenced (shRNA 4E) cells 
(Diaplan light microscope (Leitz), magnification 400X). GDNF immunostaining with a 
polyclonal anti-GDNF antibody revealed a lower signal in the shRNA 4E than in either of 
controls  (WT and Negative Control cells). Light microscope images are representative of the 
results of two independent experiments. Bar = 25 µm. (B). Changes in GDNF gene expression 
as determined by qRT-PCR (ΔΔCt method) in WT, negative control and shRNA 4E cells.  (C) 
Changes in GDNF protein expression as determined by morphometric analysis. The results 
are presented as the mean ± SD of two independent experiments performed in triplicate. 
Statistically significant differences between the shRNA 4E and the WT (* p<0.005) and 
Negative Control (** p<0.05) cells were analyzed using ANOVA with a between-within 
design and Bonferroni’s correction.  
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Figure 2. Phase-contrast inverted microscope images of silenced cells (shRNA 4E) grown 
in DMEM/F12 supplemented with 10% HI-FBS or NH OsteoDiff medium. shRNA 4E 
cells grown in osteogenic medium exhibited multilayer growth with cells retracting from 
some areas and grouping into multicellular aggregates or nodules with abundant dense 
deposits. The images (acquired with Hund Wetzlar, Wilovert, magnification 200X) are 
representative of two independent experiments. Bar = 100 µm. 
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Figure 3. Calcium detection in HK-2 cells cultured in either DMEM/F12 supplemented 
with 10% HI-FBS or NH OsteoDiff medium. (A) Light microscope images (Diaplan light 
microscope (Leitz), magnification 100-200X) of von Kossa staining reveal calcium deposits 
in some cells and nodules in the Negative Control and silenced (shRNA 4E) cells grown in 
osteogenic medium for 15 days. No calcium deposition was seen in control or silenced cells 
cultured under standard conditions (DMEM/F12 supplemented with 10% HI-FBS). Low 
magnification images showed much more abundant dark deposits in the silenced than in the 
control cells. The images are representative of two independent experiments. Bars = 100 left  
µm and 50 right µm. (B) Quantitative analysis of von Kossa staining with morphometric 
analyses on days 5 and 15. Statistically significant differences emerged between the shRNA 
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4E cells and the WT and negative control cells at 5 (*p<0.05) and 15 days (**p<0.005 shRNA 
4E vs WT and § p<0.01 vs Negative Control) using a non-parametric test (Mann-Whitney U 
test) and Primer software (McGraw-Hill).  
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Figure 4. ESEM analysis of HK-2 cells cultured in DMEM/F12 supplemented with 10% 
HI-FBS or NH OsteoDiff medium. (A) In silenced cells, ESEM images and spectra 
confirmed the presence of calcium (Ca) and phosphate (P) in the nodules on day 15 (green 
arrow). No calcium-phosphate (Ca2PO4) deposits were seen in silenced cells cultured under 
standard conditions. The images are representative of two independent experiments. Bars = 
100 µm left, 50 µm right. (B) Quantitative analysis of calcium and phosphate levels in WT, 
negative control and shRNA 4E cells grown in NH OsteoDiff medium for 15 days. Bar = 500 
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µm. Statistically significant differences emerged using a non-parametric test (Mann-Whitney 
U test), and Primer software (McGraw-Hill) (** p<0.005 shRNA vs Negative Control and 
WT). 
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Figure 5. Osteogenic-like process in wild-type (WT), negative control and silenced 
(shRNA 4E) cells grown in osteogenic NH OsteoDiff medium.  (A) left: expression of 
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Runx2 gene by qRT-PCR (ΔΔCt method); right: expression of Runx2 protein by ICW 
Fluorescence quantification at 800 nm normalized to the β-tubulin signal. (*p<0.05; 
**p<0.005 shRNA vs Negative Control and WT). (B) Expression of osteogenesis-related 
genes as determined by qRT-PCR (ΔΔCt method). Results are expressed as the ratio of nRQ 
osteonectin (ON) to nRQ osteopontin (OP) (§ p<0.01, shRNA 4E vs WT; * p<0.05, shRNA 
4E vs WT; ** p<0.005, shRNA 4E vs Negative Control). (C) ALP staining quantification by 
morphometric analysis of light microscope images (Leica DMIL LED, magnification 400X) 
(**p<0.005 shRNA vs Negative Control and WT). Alkaline phosphatase appears as an intense 
blue/purple stain in the cells (arrows). The images are representative of two independent 
experiments. Bar = 10 µm.  
Results are presented as the mean ± SD of two independent experiments performed in 
triplicate. Statistically significant differences emerged using ANOVA with a between-within 
design and Bonferroni’s correction. 
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Figure 6. Cell proliferation and viability. Results of methyl blue assay (based on optical 
density) of wild-type (WT), negative control and silenced (shRNA 4E) cell growth in standard 
(DMEM/F12 supplemented with 10% HI-FBS) and osteogenic (NH OsteoDiff) conditions. 
Data are presented as the mean ± SD of three independent experiments. Statistically 
significant differences emerged between the shRNA 4E and the wild-type and Negative 
Control cells (** p<0.005) using ANOVA with a between-within design and Bonferroni’s 
correction. 
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Figure 7. Double staining with annexin V and PI in wild-type (WT), negative control and 
silenced (shRNA 4E) cells grown in osteogenic (NH OsteoDiff) medium for  5 and 15 
days. (A) Percentages of dead and live cells. (B) Cell population (necrosis, early and late 
apoptosis) involved in the death process. Results are presented as the mean ± SD of two 
independent experiments performed in triplicate. Statistically significant differences emerged 
using ANOVA with a between-within design and Bonferroni’s correction (*p<0.05 shRNA 4E 
vs Negative Control and WT). 
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Figure 8. Immunofluorescence images of TUNEL-stained apoptotic nuclei (green 
staining) in negative control and silenced (shRNA 4E) cells grown in NH OsteoDiff 
medium for 15 days. The images (acquired using a DMI600CS-TCS SP8 fluorescence 
microscope) are representative of two independent experiments. A: Bright field; B: FITC; C: 
Merge. Bars = 50 µm and 25 µm. (D) Quantitative analysis of TUNEL staining using 
morphometric analysis. Statistically significant differences emerged between the shRNA 4E 
cells and Negative Control cells using with a non-parametric test (Mann-Whitney U test) and 
Primer software (McGraw-Hill) (** p<0.005).  
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Figure 9. Expression of apoptosis-related genes in wild-type (WT), negative control and 
silenced (shRNA 4E) cells grown in NH OsteoDiff medium. Changes in BCL2  and BAX  
mRNA levels measured using qRT-PCR (ΔΔCt). Results are presented as the mean ± SD of 
two independent experiments performed in triplicate. Statistically significant differences were 
calculated using ANOVA with a between-within design and Bonferroni’s correction (* 
p<0.05; **p<0.005 shRNA vs Negative Control and WT). 
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Figure 10. Caspase activation in wild-type (WT), negative control and silenced (shRNA 
4E) cells grown in NH OsteoDiff medium. (A) Fluorescence quantified at 800 nm and 
normalized to the β-tubulin signal. Results are presented as the mean ± SD of two 
independent experiments performed in triplicate. Statistically significant differences emerged 
using ANOVA with a between-within design and Bonferroni’s correction (*p<0.05; §p<0.005 
shRNA vs Negative Control and WT). (B) Representative image acquired at a wavelength of 
800 nm. 
 
 
